These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

609 related items for PubMed ID: 15342856

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism.
    Price CS, Thompson WW, Goodson B, Weintraub ES, Croen LA, Hinrichsen VL, Marcy M, Robertson A, Eriksen E, Lewis E, Bernal P, Shay D, Davis RL, DeStefano F.
    Pediatrics; 2010 Oct; 126(4):656-64. PubMed ID: 20837594
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. An assessment of the impact of thimerosal on childhood neurodevelopmental disorders.
    Geier DA, Geier MR.
    Pediatr Rehabil; 2003 Oct; 6(2):97-102. PubMed ID: 14534046
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines.
    Pichichero ME, Gentile A, Giglio N, Umido V, Clarkson T, Cernichiari E, Zareba G, Gotelli C, Gotelli M, Yan L, Treanor J.
    Pediatrics; 2008 Feb; 121(2):e208-14. PubMed ID: 18245396
    [Abstract] [Full Text] [Related]

  • 10. Association between thimerosal-containing vaccine and autism.
    Hviid A, Stellfeld M, Wohlfahrt J, Melbye M.
    JAMA; 2003 Oct 01; 290(13):1763-6. PubMed ID: 14519711
    [Abstract] [Full Text] [Related]

  • 11. Vaccines and autism: evidence does not support a causal association.
    DeStefano F.
    Clin Pharmacol Ther; 2007 Dec 01; 82(6):756-9. PubMed ID: 17928818
    [Abstract] [Full Text] [Related]

  • 12. [Mercury in vaccines].
    Hessel L.
    Bull Acad Natl Med; 2003 Dec 01; 187(8):1501-10. PubMed ID: 15146581
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations.
    Fombonne E, Zakarian R, Bennett A, Meng L, McLean-Heywood D.
    Pediatrics; 2006 Jul 01; 118(1):e139-50. PubMed ID: 16818529
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A two-phased population epidemiological study of the safety of thimerosal-containing vaccines: a follow-up analysis.
    Geier DA, Geier MR.
    Med Sci Monit; 2005 Apr 01; 11(4):CR160-70. PubMed ID: 15795695
    [Abstract] [Full Text] [Related]

  • 19. Of vaccine-autism, thimerosal, and metallothioneins.
    Guzzi G.
    Pediatr Allergy Immunol; 2007 Feb 01; 18(1):88; author reply 89. PubMed ID: 17295805
    [No Abstract] [Full Text] [Related]

  • 20. An evaluation of the effects of thimerosal on neurodevelopmental disorders reported following DTP and Hib vaccines in comparison to DTPH vaccine in the United States.
    Geier DA, Geier MR.
    J Toxicol Environ Health A; 2006 Aug 01; 69(15):1481-95. PubMed ID: 16766480
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.